MEDIFAST Cash And Short Term Investments vs Non Current Assets Total Analysis

MED Stock  USD 18.14  0.14  0.77%   
MEDIFAST INC financial indicator trend analysis is infinitely more than just investigating MEDIFAST INC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MEDIFAST INC is a good investment. Please check the relationship between MEDIFAST INC Cash And Short Term Investments and its Non Current Assets Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

Cash And Short Term Investments vs Non Current Assets Total

Cash And Short Term Investments vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MEDIFAST INC Cash And Short Term Investments account and Non Current Assets Total. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between MEDIFAST INC's Cash And Short Term Investments and Non Current Assets Total is 0.56. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of MEDIFAST INC, assuming nothing else is changed. The correlation between historical values of MEDIFAST INC's Cash And Short Term Investments and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of MEDIFAST INC are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Cash And Short Term Investments i.e., MEDIFAST INC's Cash And Short Term Investments and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.56
Relationship DirectionPositive 
Relationship StrengthWeak

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of MEDIFAST INC balance sheet. This account contains MEDIFAST INC investments that will expire within one year. These investments include stocks and bonds that can be liquidated by MEDIFAST INC fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from MEDIFAST INC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 6.96, whereas Tax Provision is forecasted to decline to about 26.5 M.
 2021 2022 2023 2024 (projected)
Gross Profit1.1B1.1B775.9M814.6M
Total Revenue1.5B1.6B1.1B1.1B

MEDIFAST INC fundamental ratios Correlations

0.90.910.950.960.89-0.630.910.810.90.250.790.310.190.20.810.80.890.130.960.880.990.80.190.710.85
0.90.930.910.820.79-0.460.780.660.820.40.610.250.0-0.030.760.820.780.030.910.830.890.730.00.740.79
0.910.930.970.790.75-0.620.830.780.770.370.670.10.040.030.750.850.77-0.120.960.740.920.70.040.740.76
0.950.910.970.840.82-0.630.840.790.820.280.680.080.040.060.790.90.79-0.011.00.790.960.70.040.760.77
0.960.820.790.840.85-0.650.920.80.870.220.870.490.30.30.710.630.890.220.840.860.950.810.30.620.86
0.890.790.750.820.85-0.270.740.490.990.090.530.370.330.30.960.740.90.260.860.970.810.740.320.530.77
-0.63-0.46-0.62-0.63-0.65-0.27-0.72-0.96-0.28-0.3-0.89-0.03-0.14-0.19-0.12-0.36-0.410.12-0.57-0.25-0.73-0.45-0.14-0.54-0.53
0.910.780.830.840.920.74-0.720.840.740.220.870.340.290.330.610.630.8-0.130.830.720.930.690.290.630.71
0.810.660.780.790.80.49-0.960.840.510.350.930.150.120.150.360.530.61-0.060.750.480.870.640.120.610.7
0.90.820.770.820.870.99-0.280.740.510.140.560.450.260.210.930.710.910.290.860.990.820.80.250.520.84
0.250.40.370.280.220.09-0.30.220.350.140.260.09-0.04-0.220.090.220.040.080.260.160.280.29-0.040.250.29
0.790.610.670.680.870.53-0.890.870.930.560.260.450.240.250.340.350.690.050.650.550.840.730.240.470.76
0.310.250.10.080.490.37-0.030.340.150.450.090.450.09-0.030.26-0.190.530.340.10.510.240.710.09-0.20.59
0.190.00.040.040.30.33-0.140.290.120.26-0.040.240.090.940.250.020.230.060.070.180.16-0.041.00.20.0
0.2-0.030.030.060.30.3-0.190.330.150.21-0.220.25-0.030.940.190.030.21-0.040.080.130.18-0.130.940.21-0.06
0.810.760.750.790.710.96-0.120.610.360.930.090.340.260.250.190.790.830.210.840.910.720.660.250.490.66
0.80.820.850.90.630.74-0.360.630.530.710.220.35-0.190.020.030.790.590.00.910.680.80.430.020.810.5
0.890.780.770.790.890.9-0.410.80.610.910.040.690.530.230.210.830.590.190.820.910.840.860.230.440.86
0.130.03-0.12-0.010.220.260.12-0.13-0.060.290.080.050.340.06-0.040.210.00.190.020.340.060.260.06-0.020.32
0.960.910.961.00.840.86-0.570.830.750.860.260.650.10.070.080.840.910.820.020.830.950.710.070.740.77
0.880.830.740.790.860.97-0.250.720.480.990.160.550.510.180.130.910.680.910.340.830.80.830.180.490.86
0.990.890.920.960.950.81-0.730.930.870.820.280.840.240.160.180.720.80.840.060.950.80.760.160.740.81
0.80.730.70.70.810.74-0.450.690.640.80.290.730.71-0.04-0.130.660.430.860.260.710.830.76-0.040.240.94
0.190.00.040.040.30.32-0.140.290.120.25-0.040.240.091.00.940.250.020.230.060.070.180.16-0.040.20.0
0.710.740.740.760.620.53-0.540.630.610.520.250.47-0.20.20.210.490.810.44-0.020.740.490.740.240.20.44
0.850.790.760.770.860.77-0.530.710.70.840.290.760.590.0-0.060.660.50.860.320.770.860.810.940.00.44
Click cells to compare fundamentals

MEDIFAST INC Account Relationship Matchups

MEDIFAST INC fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets194.7M276.1M398.3M316.2M309.9M325.4M
Other Current Liab49.3M57.3M84.4M69.1M48.5M50.9M
Total Current Liabilities79.4M111.4M169.8M140.9M92.3M96.9M
Total Stockholder Equity104.8M157.2M202.5M155.0M201.5M211.6M
Property Plant And Equipment Net38.8M38.1M80.6M75.6M67.1M70.5M
Net Debt(63.4M)(152.6M)(71.6M)(61.6M)(72.4M)(68.8M)
Retained Earnings168.8M154.4M190.3M139.9M174.6M183.4M
Cash77.0M163.7M104.2M87.7M94.4M99.2M
Non Current Assets Total40.5M41.8M91.5M93.4M85.9M90.2M
Non Currrent Assets Other353K2.9M6.5M12.5M14.7M15.4M
Cash And Short Term Investments92.7M174.5M109.5M87.7M150.0M157.5M
Net Receivables1.0M1.4M584K0.08.7M9.2M
Common Stock Shares Outstanding12.1M11.9M11.8M11.3M10.9M12.2M
Liabilities And Stockholders Equity194.7M276.1M398.3M316.2M309.9M325.4M
Non Current Liabilities Total10.4M7.5M26.0M20.3M16.1M16.9M
Inventory48.8M53.4M180.0M118.9M54.6M27.8M
Other Current Assets11.3M12.3M17.3M16.2M19.4M20.4M
Other Stockholder Equity(64.0M)2.8M12.0M15.2M26.6M27.9M
Total Liab89.8M118.8M195.9M161.2M108.4M113.8M
Property Plant And Equipment Gross38.8M38.1M113.3M115.6M114.4M120.1M
Total Current Assets154.2M234.3M306.9M222.8M224.0M235.2M
Short Term Debt3.2M7.3M6.5M5.8M11.8M12.4M
Accounts Payable22.6M36.1M70.9M58.7M39.2M21.4M
Accumulated Other Comprehensive Income25K41K111K24K248K260.4K
Other Assets1.7M14.1M10.9M17.8M20.5M21.5M
Short Term Investments15.7M10.8M5.4M(23K)55.6M58.4M
Property Plant Equipment26.0M27.6M56.1M57.2M65.8M69.1M
Net Tangible Assets104.8M157.2M202.5M155.0M178.3M125.0M
Retained Earnings Total Equity168.8M154.4M190.3M139.9M160.8M126.9M
Capital Surpluse0.07.8M12.0M21.6M19.4M10.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.95)
Earnings Share
0.67
Revenue Per Share
61.769
Quarterly Revenue Growth
(0.41)
Return On Assets
0.0477
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.